48 EVALUATION OF THE DIAGNOSTIC ACCURACY OF MULTIDETECTOR COMPUTER TOMOGRAPHY UROGRAPHY (MDCTU) FOR DIAGNOSING BLADDER CANCER IN PATIENTS PRESENTING WITH MACROSCOPIC HAEMATURIA OVER 40 YEARS OF AGE

2010 ◽  
Vol 9 (2) ◽  
pp. 48-49
Author(s):  
C.G.T. Blick ◽  
B.W. Turney ◽  
S. Nazir ◽  
J.P. Crew ◽  
N.C. Cowan
2014 ◽  
Vol 39 (5) ◽  
pp. e308-e312 ◽  
Author(s):  
Eugenio Brunocilla ◽  
Francesco Ceci ◽  
Riccardo Schiavina ◽  
Paolo Castellucci ◽  
Anna Margherita Maffione ◽  
...  

Author(s):  
Shaoxu Wu ◽  
Xiong Chen ◽  
Jiexin Pan ◽  
Wen Dong ◽  
Xiayao Diao ◽  
...  

Abstract Background Cystoscopy plays an important role in bladder cancer (BCa) diagnosis and treatment, but its sensitivity needs improvement. Artificial intelligence has shown promise in endoscopy, but few cystoscopic applications have been reported. We report a Cystoscopy Artificial Intelligence Diagnostic System (CAIDS) for BCa diagnosis. Methods In total, 69,204 images from 10,729 consecutive patients from six hospitals were collected and divided into training, internal validation, and external validation sets. The CAIDS was built using a pyramid scene parsing network and transfer learning. A subset (n = 260) of the validation sets was used for a performance comparison between the CAIDS and urologists for complex lesion detection. The diagnostic accuracy, sensitivity, specificity, and positive and negative predictive values and 95% confidence intervals (CIs) were calculated using the Clopper-Pearson method. Results The diagnostic accuracies of the CAIDS were 0.977 (95% CI = 0.974–0.979) in the internal validation set and 0.990 (95% CI = 0.979–0.996), 0.982 (95% CI = 0.974–0.988), 0.978 (95% CI = 0.959–0.989), and 0.991 (95% CI = 0.987–0.994) in different external validation sets. In the CAIDS versus urologists’ comparisons, the CAIDS showed high accuracy and sensitivity (accuracy = 0.939, 95% CI = 0.902–0.964; and sensitivity = 0.954, 95% CI = 0.902–0.983) with a short latency of 12 s, much more accurate and quicker than the expert urologists. Conclusions The CAIDS achieved accurate BCa detection with a short latency. The CAIDS may provide many clinical benefits, from increasing the diagnostic accuracy for BCa, even for commonly misdiagnosed cases such as flat cancerous tissue (carcinoma in situ), to reducing the operation time for cystoscopy.


2020 ◽  
Author(s):  
Xinyue Ge ◽  
Zhong-Kai Lan ◽  
Jing Chen ◽  
Shang-Yong Zhu

Aim: The study retrospectively analysed the accuracy of preoperative contrast-enhanced ultrasound (CEUS) in differenti-ating stage Ta-T1 or low-grade bladder cancer (BC) from stage T2 or high-grade bladder cancer. Material and methods: We systematically searched the literature indexed in PubMed, Embase, and the Cochrane Library for original diagnostic articles of bladder cancer. The diagnostic accuracy of CEUS was compared with cystoscopy and/or transurethral resection of bladder tumors (TURBT). The bivariate logistic regression model was used for data pooling, couple forest plot, diagnostic odds ratio (DOR) and summary receiver operating characteristic (SROC). Results: Five studies met the selection criteria; the overall number of reported bladder cancers patients were 436. The pooled-sensitivity (P-SEN), pooled-specificity (P-SPE), pooled-positive likelihood ratio (PLR+), pooled-negative likelihood ratio (PLR−), DOR, and area under the SROC curve were 94.0% (95%CI: 85%–98%), 90% (95%CI: 83%–95%), 9.5 (95%CI: 5.1–17.6), 0.06 (95%CI: 0.02–0.17), 147 (95%CI: 35–612) and 97% (95% CI: 95%–98%) respectively. Conclusion: CEUS reaches a high efficiency in discriminating Ta-T1 or low-grade bladder cancer from stage T2 or high-grade bladder cancer. It can be a promising method in patients to distinguish T staging and grading of bladder cancer because of its high sensitivity, specificity and diagnostic accuracy.


1987 ◽  
Vol 2 (2) ◽  
pp. 121-124 ◽  
Author(s):  
Alessandro Tizzani ◽  
Giovanni Cassetta ◽  
Anna Cicigoi ◽  
Paolo Piana ◽  
Antonella Cerchier ◽  
...  

This study was carried out to evaluate the usefulness of determining urinary levels of carcinoembryogenic antigen (CEA), tissue-polypeptide antigen (TPA), and gastrointestinal cancer antigen (Cal 9-9) in addition to the usual diagnostic procedures for bladder cancer. Sixty-seven patients with transitional bladder cancer, 40 healthy controls and 20 patients with inflammatory diseases of the urinary tract were considered. All urine samples were obtained from patients with intact renal function and no urinary tract infection. TPA and Cal 9-9 urinary levels in patients with G3 bladder tumors were significantly higher than in those with lower graded neoplasms. The sensitivity, specificity, and predictive value of a positive (PV+) or negative (PV–) test and the diagnostic accuracy were also evaluated. Cal 9-9 was the best urinary marker for bladder cancer (sensitivity 71.6%, specificity 91.6%, PV + 90.5%, PV–74.3%, diagnostic accuracy 81%).


2018 ◽  
Vol 122 (5) ◽  
pp. 744-753 ◽  
Author(s):  
Niket Gandhi ◽  
Satheesh Krishna ◽  
Christopher M. Booth ◽  
Rodney H. Breau ◽  
Trevor A. Flood ◽  
...  

Epigenomics ◽  
2018 ◽  
Vol 10 (5) ◽  
pp. 673-687 ◽  
Author(s):  
Judith Bosschieter ◽  
Catrin Lutz ◽  
Loes I Segerink ◽  
André N Vis ◽  
Ellen C Zwarthoff ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document